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ABSTRACT 
 
Sonoporation has been shown able to deliver drugs across cell membranes and into target 
cells, yet several limitations have prohibited further advancement of this technology. 
Higher delivery rates were associated with increased cellular death, thus implying a 5 
safety-efficacy trade-off. Meanwhile, there has been no reported study of safe in vitro 
sonoporation in a physiologically relevant flow environment. The objective of our study 
was not only to evaluate sonoporation under physiologically relevant flow conditions, 
such as fluid velocity, shear stress, and temperature, but also to design ultrasound 
parameters that exploit the presence of flow to maximize sonoporation efficacy while 10 
minimizing or avoiding cellular damage. Human umbilical vein endothelial cells 
(EA.hy926) were seeded in flow chambers as a monolayer to mimic the endothelium. A 
peristaltic pump maintained a constant fluid velocity of 12.5 cm/s. A focused 0.5 MHz 
transducer was used to sonicate the cells, while an inserted focused 7.5 MHz passive 
cavitation detector monitored microbubble-seeded cavitation emissions. Under these 15 
conditions, propidium iodide, which is normally impermeable to the cell membrane, was 
traced to determine whether it could enter cells after sonication. Meanwhile, calcein-AM 
was used as a cell viability marker. A range of focused ultrasound parameters was 
explored, with several unique bioeffects observed: cell detachment, preservation of cell 
viability with no membrane penetration, cell death, and preservation of cell viability with 20 
sonoporation. The parameters were then modified further to produce safe sonoporation 
with minimal cell death. To increase the number of favourable cavitation events, we 
lowered the ultrasound exposure pressure to 40kPapk-neg and increased the number of 
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cavitation nuclei by 50 times, to produce a trans-membrane delivery rate of 62.6 ± 4.3% 
with a cell viability of 95% ± 4.2%. Furthermore, acoustic cavitation analysis showed 
that the low pressure sonication produced stable and non-inertial cavitation throughout 
the pulse sequence. To our knowledge, this is the first study to demonstrate a high drug 
delivery rate coupled with high cell viability in a physiologically relevant in vitro flow 5 
system. 
 
Key Words:  microbubbles; ultrasound; trans-membrane drug delivery; sonoporation; 
endothelial cells; EA.hy926   
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INTRODUCTION 
 
Focused ultrasound (FUS) techniques are being developed to drive acoustic 
cavitation – acoustically driven microbubble activity – and produce therapeutic biological 
effects at specified locations (Dalecki, 2004; Stride and Coussios, 2010). Amongst a 5 
multitude of methods, trans-membrane molecular delivery has been of great interest due 
to its potential to address one of the most pressing challenges with pharmaceuticals: drug 
transport into cells. The application of FUS and microbubbles facilitates trans-membrane 
transport by generating acoustic cavitation at or near the cell membrane, but the exact 
physical and biological mechanisms involved remain unknown (Schlicher et al., 2006; 10 
Zeghimi et al., 2012). Proposed routes of molecular delivery include the formation of 
short-lived pores in the membrane, also known as sonoporation (Yu and Xu, 2014), and 
endocytosis (Geers et al., 2011; van Wamel et al., 2006). In addition, increased trans-
membrane delivery efficiency is associated with increased damage and cell death (Qiu et 
al., 2012, 2010), and this efficacy-safety trade-off has limited the technology’s 15 
development and hence it remains unutilized in the clinic as a drug delivery tool. 
Ultrasonic trans-membrane delivery requires microbubbles undergoing acoustic 
cavitation to act near or on the surface of the cell membrane (Ohl et al., 2006; Prentice et 
al., 2005; Zhou et al., 2012). Ultrasound is typically generated from a focused transducer 
outside the body and can propagate several centimeters into the body to converge to a 20 
small focal volume. Microbubbles, which are typically 1 – 10 μm in diameter, coated 
with a protein, polymer, or lipid shell, and filled with a stabilized gas core, are then 
systemically administered so that they circulate the body’s diverse vasculature. 
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Microbubbles are clinically approved and being used as contrast agents in ultrasound 
imaging (Cosgrove, 2006). However, their use is extended to therapeutic applications 
such as sonoporation and targeted drug delivery applications (Ferrara et al., 2007). 
Microbubbles can flow at speeds varying from 20 cm/s in the middle of the vessel to a 
few mm/s near the vessel wall, which correlate well with the velocity of red blood cells 5 
(Levine et al., 1984). When exposed to ultrasound, microbubbles respond in a complex 
range of behaviors known as acoustic cavitation (Apfel, 1997). Ultrasound exposure 
parameters, such as center frequency, peak-rarefactional pressure, pulse length, pulse 
repetition frequency, etc. can be adjusted to control the cavitation magnitude, duration 
and distribution (Choi and Coussios, 2012; Dalecki, 2004). 10 
Depending on the ultrasound parameters employed, the physical composition of the 
microbubbles under ultrasound exposure, and the environment surrounding the 
microbubble, different types of cavitation can occur. Microbubbles undergoing acoustic 
cavitation are expanding and contracting in response to the compressional and 
rarefactional phases of the ultrasound wave (Apfel, 1997; Helfield and Goertz, 2013). At 15 
low acoustic pressures, microbubbles recurrently oscillate around an equilibrium radius in 
a behavior known as stable cavitation (Apfel, 1997; Dalecki, 2004; Morgan et al., 2000). 
Transient cavitation describes short-lived phenomena, which can be caused by 
fragmentation of the shell, dissolution of the core gas, or other mechanisms (Apfel, 1997; 
Chomas et al., 2001; Newman and Bettinger, 2007). One cause of a transient response is 20 
inertial cavitation, which arises when the rarefactional phase of the ultrasound pulse 
results in a radial expansion followed by a violent collapse dominated by the inertia of the 
surrounding liquid medium (Church and Carstensen, 2001; Flynn, 1982). 
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The different types of acoustic cavitation have been demonstrated to produce 
diverse cellular effects (Fan et al., 2014; Mehier-Humbert et al., 2005; Qiu et al., 2010). 
First, it has been shown that the interaction between the microbubble oscillation and the 
cell membrane can produce short-lived pores that allow drug uptake. These pores are up 
to 1 μm in size and have been shown to reseal within seconds (Hu et al., 2013; Newman 5 
and Bettinger, 2007; Qiu et al., 2010; Zhou et al., 2009), minutes (Schlicher et al., 2006) 
or even hours (Zhao et al., 2008). Inertial cavitation produces higher rates of intracellular 
delivery than stable cavitation (Fan et al., 2013; Karshafian et al., 2009; Park et al., 2011; 
Qiu et al., 2010), however the cellular membrane is more likely to be disrupted and that 
influences cell viability (Newman and Bettinger, 2007). Furthermore, at diagnostic 10 
frequencies and acoustic pressures, endothelial damage can occur when contrast agents 
are under ultrasound exposure, due to the generation of inertial cavitation. Such 
cavitation resulted in severe cell erosion from in vitro static monolayers (Brayman et al., 
1999) and in cell lysis (Ward et al., 1999). Thus, non-inertial cavitation is deemed safer in 
comparison to inertial cavitation, due to its reduced effect on cell viability (Qiu et al., 15 
2012). 
Different ultrasound exposure parameters for sonoporation have resulted in 
different cellular effects (Fan et al., 2014). These parameters include the center frequency 
of the ultrasound transducer, the acoustic pressure, the pulse length, the pulse repetition 
frequency, etc. As the number of ultrasound pulses increased, cell viability decreased 20 
(Park et al., 2011). Severe cell damage was also associated with the acoustic pressure of 
the applied pulses. As the acoustic pressure increases, damage increases in a generally 
linear fashion (Brayman et al., 1999; Qiu et al., 2010). Thus, an ultrasound pulse 
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sequence must be designed to fulfill the requirement of both minimum cell damage and 
maximum desired bioeffect.  
Previous studies have utilized a diverse range of experimental setups, ultrasound 
parameters, microbubble formulations, and cell types which resulted in large variations in 
delivery rates (Yu and Xu, 2014). Intracellular drug delivery in human umbilical vein 5 
endothelial cells (HUVECs) was shown to depend on the experienced shear conditions, 
with the observed rates being below 10% in the physiologically relevant scenario (Park et 
al., 2011). Previous research which focused on sonoporation applied to modulate gene 
expression in HUVECs led to a transfection rate of 25% (Guo et al., 2004). More 
recently, GFP reporter plasmids were delivered to HEK294 cells with an efficiency of up 10 
to 80% (Tlaxca et al., 2010). A similar delivery rate was achieved at high pressures in the 
DNA transfection of MCF-7 cells (Qiu et al., 2010). However, high delivery rates were 
accomplished at the expense of cell viability, with extended cell death being observed at 
high pressure sonication (Ppk-neg > 500kPa); in contrast, low acoustic pressures (Ppk-neg <  
100kPapk-neg) were proved to be safer but resulted in transfection efficiency below 15% 15 
(Qiu et al., 2012). A common feature of most of the aforementioned studies is that 
experiments were conducted in the absence of flow.  
The presence of flow is associated with various physical effects such as shear 
stress, since endothelial cells in the human body are exposed to blood flow. 
Hemodynamic effects largely influence cells exposed to blood flow (Garcia-Cardeña et 20 
al., 2001). Furthermore, shear stress increases endothelial cell adhesion to the substratum 
(Dardik et al., 1999) and alters gene expression and thereby its phenotype (Morita et al., 
1993). Endothelial cells are predominantly affected by flow conditions, both in terms of 
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function (Balcells et al., 2010; Sato and Ohashi, 2005) and morphology (Rouleau et al., 
2010). Cells cultivated under shear stress conditions prior to sonoporation showed lower 
percentage responses of drug uptake in comparison to static cultured cells after sonication 
(Park et al., 2011), revealing that physiologically-relevant growth conditions render 
endothelial cell membrane less prone to ultrasound-mediated trans-membrane delivery. 5 
An additional advantage of the presence of flow is that the ultrasound pulse sequence can 
be modified in order to uniformly distribute the acoustic cavitation activity within the 
focal volume (Pouliopoulos et al., 2014). Furthermore, the cavitation nuclei kinetics 
within the focal volume can be adjusted by varying the pulse-off time (Goertz et al., 
2010). Although it has been previously shown that the employed pulse sequence 10 
parameters greatly influence the cell viability and membrane permeability (Karshafian et 
al., 2009), there has been no feasibility study on a physiologically relevant flow setup. 
The aim of our study was (1) to determine whether acoustic cavitation-mediated 
trans-membrane molecular delivery can be produced at low acoustic pressures during 
physiologically relevant flow conditions and (2) to rationally modify the ultrasound 15 
parameters in order to maximize trans-membrane delivery efficacy while minimizing 
cellular damage. In this feasibility study, we will demonstrate a high cavitation-mediated 
trans-membrane delivery rate, coupled with enhanced cell viability, using vascular 
endothelial cells in vitro under arterial flow conditions.  
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METHODS 
 
In vitro cell culture  
Vascular endothelial cells were used due to their importance in cardiovascular 
pathologies and due to the feasibility of targeting them in vivo for the treatment of 5 
atherosclerosis. The human umbilical vein cell line (EA.hy926; CRL-2922; ATCC 
Manassas, VA, USA) was used in the experiments. The cells were cultured in phenol red 
free DMEM medium (11880-036; Invitrogen, Life Technologies, Carlsbad, CA, USA) 
and were maintained in a humidified incubator at standard conditions (37°C, 5% CO2). 
The medium was renewed every 2 – 3 days. The EA.hy926 cells were sub-cultured in 75 10 
cm
2
 flasks in the absence of flow until they reached 70 – 90% confluence.  
 
Microbubbles manufacturing 
Microbubbles were manufactured in-house following previously described 
protocols (Banerjee et al., 2012; Pouliopoulos et al., 2014) and were composed of a 15 
phospholipid shell and a perfluorobutane gas core.  The microbubble shell consisted of 
three lipids (Avanti Polar Lipids Inc., AL, USA) originally in powder form: DPPC 
(Dipalmitoylphosphatidylcholine), DPPA (Dipalmitoylphosphatidic acid), and DPPE-
PEG 5000 (dipalmitolyphosphatidylethanolamine–PEG5000) which were mixed and 
diluted with glycerol (5% v/v) and saline (80% v/v). Before each experiment, 20 
perfluorobutane gas (FluoroMed L.P., Texas, USA) was introduced into the phospholipid 
mixture and the solution was mechanically activated using an amalgamator (Synergy 
Electronics, Scottsdale, AZ, USA). The microbubbles were counted and sized using 
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optical microscopy and a previously described image processing technique (Sennoga et 
al., 2010). The average microbubble concentration was found to be 7.3 ± 4 × 10
9 
microbubbles/ml with an average size of 1.62 ± 0.87 μm, while excluding bubbles with 
diameters below 0.5μm. The clinically recommended dose for Definity contrast agents is 
0.02 ml/kg (Unger et al., 2004). Our in-house manufactured microbubbles were diluted to 5 
match this concentration. Taking into consideration an average body weight of 70 kg and 
a blood volume of 5 L, the acceptable equivalent dose would be equal to a concentration 
of approx. 2 × 10
6
 microbubbles/ml. Microbubble concentrations at 1x and 50x the 
clinically recommended dose were used.  
 10 
In vitro flow setup  
Our in vitro experiments were conducted in physiologically relevant flow 
conditions. EA.hy926 cells were seeded in sterile collagen treated flow chambers 
(collagen IV coated μ-Slide I0.4, Ibidi, Martinsried, Germany) at a concentration of 1.5 × 
10
5
 cells/ml (± 4 × 10
2
 cells/ml) and grown as a monolayer for 24 hours. Flow was 15 
applied to the adherent cells for this time period in order to restore their physiological 
phenotype and functionality (Li et al., 2005). The cell chamber outlet was connected to 
tubing that ran into a flask containing the cell culture medium, propidium iodide (PI), and 
the microbubbles. The flask outlet was connected to a tube that ran into the inlet of the 
chamber, which in turn was attached to a peristaltic pump (MPII Mini-Peristaltic Pump; 20 
Harvard Apparatus, Holliston, MA, USA) that maintained a fluid velocity of 12.5 cm/s 
and a flow rate of 24.5 ml/min (figure 1(a)). The velocity was chosen to match the 
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measured blood speed in the vicinity of atherosclerotic plaque formed at a carotid artery 
bifurcation (Zarins et al., 1983). 
 
Cell Staining  
In the present study, calcein-AM and PI were used to track cell viability and drug 5 
delivery, respectively. Calcein-AM (C3099; Life Technologies, Carlsbad, CA, USA) is a 
cell permeable and non-fluorescent compound that is hydrolyzed by intracellular esterase 
into a green fluorescent anion with excitation and emission wavelengths of 495 and 516 
nm, respectively. The presence and activity of these esterases imply cell viability. PI 
(P4170-100MG; Sigma-Aldrich, St. Louis, MO, USA) is a red fluorescent dye with an 10 
excitation wavelength of 536 nm and an emission wavelength of 617 nm; fluorescent 
emission is triggered upon its binding with the double stranded nucleic acids. PI is 
normally impermeable to the cell membrane of viable cells despite its relatively small 
size (668.4 Da) and has been previously used as sonoporation indicator (Fan et al., 2012; 
Kooiman et al., 2011; Park et al., 2011; van Wamel et al., 2006). Successful trans-15 
membrane delivery would thus facilitate the passage of PI into the nucleus of the cell 
while maintaining viability and would result in the co-localization of green and red 
fluorescence. Calcein-AM at a concentration of 1μM per chamber was added 20 min 
prior to sonication to track cell viability and the cell monolayer was imaged 15 minutes 
afterwards. After imaging the monolayer, the chamber was washed with phenol red free 20 
DMEM to remove any excess calcein-AM and PI was introduced at a concentration of 25 
μg/ml.  
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Focused ultrasound system 
A single-element spherical-segment FUS transducer with a center frequency of 
0.5MHz (active diameter: 64mm, FWHM: 5.85mm, focal length: 62.6mm, part number: 
H107; Sonic Concepts Inc., Bothel, WA, USA) was used to drive acoustic cavitation 
activity while an inserted focused 7.5 MHz single-element focused transducer (diameter: 5 
12.7mm, focal length: 60mm, part number: U8423589; Olympus Industrial, Essex, UK) 
served as a passive cavitation detector (PCD) and was used to passively detect 
microbubble acoustic emissions (figure 1(a)). The two transducers were co-axially 
aligned so that their focal volumes overlapped. A 0.2mm polyvinylidene fluoride (PVDF) 
hydrophone (Precision Acoustics Ltd., Dorchester, UK) was used to determine the focal 10 
regions and the emitted acoustic pressures. The attenuation of the Ibidi chamber inclusive 
of both the front and back wall was found to be 19.3%. This attenuation value is likely 
even less within the chamber.. The cell flow chamber was positioned within the focal 
volume of the 0.5MHz transducer so that its focal point was placed over the target layer 
of cells (figure 1(a)). The ultrasound transducers and flow chamber were placed in a large 15 
tank containing deionized and degassed water maintained at 37°C to imitate in vivo 
conditions. 
A waveform generator (Agilent Technologies 33500B Series, Santa Clara, CA, 
USA) connected to a 50 dB power amplifier (Precision Acoustics Ltd, Dorchester, UK) 
and a matching network (SonicConcepts Inc., Bothel, WA, USA) was used to drive the 20 
0.5 MHz FUS transducer. Ultrasound parameters, such as peak negative acoustic pressure 
(Ppk-neg), pulse length (PL), pulse repetition frequency (PRF), and number of pulses (Np) 
were set for every experiment using Matlab (The Mathworks, Natick, MA, USA), which 
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controlled the emission and acquisition processes. The 7.5 MHz PCD was connected to a 
1.25 MHz high-pass filter (part number: ZFHP-1R2-S+; Mini-Circuits, Surrey, UK) or a 
5MHz high-pass filter (part number: MH-500P-C-P; Allen Avionics, Mineola, NY, USA) 
and a 28 dB pre-amplifier (Stanford Research Systems, Sunnyvale, CA, USA), to cut off 
the fundamental frequency signal and amplify low amplitude acoustic emissions specific 5 
to microbubble cavitation respectively. An 8-bit oscilloscope (DPO3014, Tektronix, Inc. 
OR, USA) was used to capture the acoustic signal at a sampling rate of 50 MSa/s. 
 
Experimental protocol 
Confluency, viability, and drug delivery into EA.hy926 cells were measured before 10 
and after sonication using a Zeiss Palm MicroBeam microscope (Zeiss Palm MicroBeam, 
Carl Zeiss AG, Oberkochen, Germany). Fifteen minutes prior to sonication, calcein-AM 
was added to the flow chamber to evaluate cell confluency. Images were captured at five 
positions throughout the cell chamber: near the inlet, midpoint between the inlet and the 
sonicated region, the sonicated region, midpoint between the sonicated region and the 15 
outlet, and near the outlet (figure 1(b)). At each zone, two images were captured at 
exposure times of 15 and 30 ms to acquire images with acceptable intensity. Immediately 
after sonication, the cells were imaged serially until trans-membrane drug delivery was 
observed or until 2 hours after sonication. Between each image acquisition, the treated 
cells were moved to a humidified incubator and kept in standard conditions (37
o
C, 5% 20 
CO2) without being exposed to flow. 
A total of 18 different sets of ultrasound parameters (Ppk-neg: 40-160kPa, PL: 10-500 
cycles, Np: 10-600) were evaluated in our experiments in two different phases: a rough 
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exploration of ultrasound parameters that would produce distinct bioeffects, and a 
quantitative study on the effects of the best parameter set discovered that could enhance 
trans-membrane drug delivery without increasing damage. In the first phase, the 
systematic exploration of parameters – by modification of one parameter at a time – was 
considered, because it could provide insight into the influence of each parameter. 5 
However, modifying a single ultrasound parameter at a time does not imply modifying a 
single characteristic of microbubble dynamics (e.g., a type, a magnitude, a spatial 
distribution, and a temporal duration of cavitation; and microbubble velocities and 
aggregation due to radiation forces). Thus, we sought modification of several parameters 
simultaneously based on evidence provided from unsuccessful parameters to produce the 10 
desired bioeffect. We have included in this paper only 3 sets that described the wide 
range of bioeffects that were observed. In the final phase, we quantitatively characterised 
the effects of the best parameter set that achieved the objective. The trans-membrane 
delivery with the optimal parameter set was compared to three controls. The first control 
experiment tested the effect of flow only on cells, without FUS or microbubbles. The 15 
second control tested the effect of flow and FUS, while the third control tested the effect 
of the presence of flow and microbubbles only. 
 
Analysis of cell viability 
The fluorescent cell images of calcein-AM and PI were processed and analyzed 20 
using ImageJ (1.47v, National Institute of Health, USA). The image was converted into a 
binary format and any merged cells were manually separated. The total number of cells in 
the image and the position of each single-cell area were determined using built-in ImageJ 
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functions. The aforementioned process was performed for both green and red fluorescent 
images, corresponding to the calcein-AM and PI fluorescent emissions respectively. The 
overlap of the two colors was counted using ImageJ and the final outcome represented 
the number of successful trans-membrane delivery without cell death.  
 5 
Post-sonoporation image analysis  
Three distinct types of cells within the focal area were identified in the post-
sonoporation image. Type A cells were defined as viable non-sonoporated cells, type B as 
non-viable sonoporated cells, and type C as viable and sonoporated cells. Non-sonicated 
cells served as a control. For the successful sonoporation experiments, calcein-AM and PI 10 
channels were segmented into two different intensity classes in Matlab, namely upper and 
lower, using arbitrary thresholds determined by qualitative interpretation of the intensity 
histograms. The upper class contained pixels with intensity above the defined threshold 
(characterized as calcein-AM or PI positive), while the lower class contained pixels with 
intensity values below the threshold (characterized as calcein-AM or PI negative, i.e. 15 
noise). Type A cells had intensity values in the upper green and lower red class, type B 
cells had values in the upper red and lower green class, and type C cells’ fluorescence 
lied within the upper class both in the calcein-AM and the PI channel. Thirty randomly 
selected cells of each type were segmented, labeled and independently analyzed in terms 
of their fluorescence intensity. Finally, lateral intensity profiles across a cell of each type 20 
were extracted to compare the spatial evolution of calcein-AM and PI fluorescence. 
 
Analysis of Cavitation Emissions 
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Acoustic emissions captured using the 7.5 MHz PCD were analyzed in order to 
monitor the activity of the flowing cavitation nuclei. Analysis was conducted in terms of 
energy and spectral content of the microbubble emissions. Energy values were 
determined by integrating the time-domain PCD signal over time and were corrected for 
the electronic noise contribution (Pouliopoulos et al., 2014). Acoustic emissions were 5 
also spectrally analyzed in order to elucidate the temporally resolved microbubble 
activity during the entire sonication duration.  
 
Statistical Analysis 
Statistical tests were performed to ensure statistical significance of our results. The 10 
data sets for the different cell types were compared using one-way analysis of variance 
(ANOVA) tests followed by post-hoc Bonferroni analysis, both for the calcein-AM and 
the PI fluorescence. The significance level adopted was 0.001p  . All measurements are 
expressed as mean ± standard deviation.  
  15 
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RESULTS 
 
Evaluation of ultrasound parameters for sonoporation during flow 
In order to identify ultrasound parameters suitable for trans-membrane delivery 
under high flow rates, we first performed a rough parametric search and evaluated 5 
performance using qualitative observations. A series of pilot experiments were performed 
during the evaluation procedure of our flow system, using typical sonoporation 
ultrasound parameters (Ppk-neg: 40-160kPa, PL: 10-500 cycles, Np: 10-600). Our initial 
selection of ultrasound parameters was based on previous studies without flow, which 
have shown that higher acoustic pressures increase not only the desired trans-membrane 10 
delivery efficiency, but also the unwanted cellular damage (Brayman et al., 1999; Qiu et 
al., 2012). Studies have also shown that inertial cavitation is responsible for the decreased 
cell viability (Newman and Bettinger, 2007). Yet there have been reports of successful 
trans-membrane delivery while maintaining cell viability, but this has been limited to a 
very small percentage of the total sonicated cell population (Lammertink et al., 2014; Qiu 15 
et al., 2012, 2010). Our rationale in the design of ultrasound pulse sequences was that 
these particular cells were sonoporated due to a specific range of the locally experienced 
cavitation dynamics, which can be controlled by the ultrasound pulse shape. If this type 
of cavitation was identified, then it could be replicated over a larger number of cells by 
exploiting the presence of flow and adjusting the pulse repetition frequency accordingly. 20 
In this paper we will present three sets of parameters that summarize the distinct observed 
bioeffects and our pulse shape and sequence design rationale. 
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The first pulse shape evaluated was characterized by a center frequency (fc) of 0.5 
MHz, a Ppk-neg of 110 kPa, and a PL of 100 cycles. This pulse was emitted 50 times at a 
PRF of 0.2 Hz. Taking into account the high flow velocity of the circulating solution 
(12.5cm/s) and the lateral FWHM of our therapeutic transducer (5.85mm), complete 
reperfusion of the focal volume was expected to occur in approximately 50ms. Thus, a 5 
PRF of 20Hz or lower would suffice for cavitation nuclei replenishment. The PRF of 
0.2Hz was selected to allow enough time (≈ 5sec) for the recording and transfer of the 
acoustic emissions data to the PC. Before sonication, it was confirmed that cells had 
covered the entire focal area and that calcein-AM had been adequately uptaken (figure 
2(a)). During sonication with the initial parameters and circulation of microbubbles at 1X 10 
the clinical dose, cells were dislodged from the flow chamber, while causing an increase 
in PI without co-localisation of calcein-AM, thus indicating cell death (figure 2(b)).  
In order to avoid cell death and dislodgement we reduced the pressure and pulse 
length (fc: 0.5 MHz, Ppk-neg: 75 kPa, PL: 50 cycles, PRF: 0.2 Hz, and Np: 50), while 
maintaining the microbubble concentration at 1x the clinical dose. The most striking 15 
observations were that no or few cells were dislodged and that the number of dead type B 
cells was significantly reduced. Interestingly, there was a total of 4 type C cells with co-
localisation of green and red fluorescence within the focal area (figure 2(c)), thus 
indicating a limited trans-membrane delivery of PI (<1%) while maintaining cell viability 
(>99%). This result indicated that safe sonoporation was feasible if the cell experiences a 20 
mild cavitation effect.  
 
Analysis of safe trans-membrane delivery 
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We assumed that higher pressures were responsible for the dead cells whilst the 
type of cavitation which locally resulted in safe trans-membrane delivery was being 
produced by a very small subset of microbubbles. Therefore, the pressure was further 
lowered, the number of pulses was increased, and the microbubble concentration was 
increased to 50x the clinical dose. Sonication with the adjusted parameters (fc: 0.5 MHz, 5 
Ppk-neg: 40 kPa, PL: 50 cycles, PRF: 0.2 Hz, and Np: 500) was shown to produce the 
desired uniform bioeffect, resulting in successful trans-membrane PI delivery with 
limited cell death. This effect was constrained within the sonicated focal area and was not 
present in the control areas near the inlet and outlet of the seeded chamber (data not 
shown). Control experiments with the same sonication parameters but without 10 
microbubbles and/or ultrasound (figures 3(a)-3(c) and table 1) confirmed that 
sonoporation occurred only due to the combined use of microbubbles and focused 
ultrasound. Following ultrasound exposure, red and green fluorescence co-localization 
was observed within the focal region (figure 3(e)), surrounded by a sharp boundary of 
viable cells that did not experience ultrasound exposure (figures 3(d) and 3(f)). Using the 15 
pre- and post-sonication images, we measured a drug delivery rate of 62.6 ± 4.3% (n=2) 
and a cell viability of 95 ± 4% (table 1). 
 All three cell types were observed within the sonicated region (figure 3(e)), 
indicating that despite the presence of flow cavitation activity was not uniformly 
distributed throughout the focal area. The stochastic nature of the cavitation events led to 20 
instances of either unsuccessful (type A) or excess (type B) membrane disruption (figure 
4(a)). However the majority of the cells were viable and successfully sonoporated (type 
C).  Intensity profiles revealed that type A and B cells presented PI and calcein-AM 
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fluorescence below the noise level respectively, as expected. In contrast, type C cells 
fluorescence was above the noise level for both channels (figure 4(b)). Type B cell type 
had a significantly different calcein-AM and PI fluorescence intensity when compared 
with the Type A control ( 0.001p  , figure 4(c)). Similarly, both channels presented 
statistically significant difference between the type B and type C cells. In contrast, type C 5 
cells showed significantly higher intensity levels than type A cells only in the PI channel, 
with the change in calcein-AM mean intensity being non-significant ( 0.05p  , figure 
4(c)). Interestingly, the mean green fluorescence of type A and C cells was approximately 
70% lower than the green fluorescence outside the insonation region which acted as a 
control (figures 3(d) and 3(f)) but still above the defined threshold. The average 10 
intensities of each cell type were insensitive to changes of either the green fluorescence 
threshold or the total number of the randomly selected cells. 
 
 Acoustic emissions from cavitation activity 
Analysis of the acoustic emissions from the cavitation activity showed that microbubbles 15 
persisted throughout the entire pulse sequence. Following correction for the electronic 
noise contribution, the energy of the microbubble emissions for the first set of the tested 
parameters (fc: 0.5 MHz, Ppk-neg: 110 kPa, PL: 100 cycles, PRF: 0.2 Hz, and Np: 50) 
showed large inter-pulse variations following a decreasing trend (figure 5(a)), while the 
energy of the final set of parameters (fc: 0.5 MHz, Ppk-neg: 40 kPa, PL: 50 cycles, PRF: 0.2 20 
Hz, and Np: 500) was lower and decayed with time (figure 5(c)). This could be due to 
either the gradual decrease in the circulating microbubble concentration, or the gradual 
change of the microbubble sizes. In contrast, no detectable emissions were recorded in 
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the control experiment without circulating microbubbles. The low peak-rarefactional 
pressures (Ppk-neg: 40-110 kPa) were not expected to trigger transient inertial cavitation 
events. This was confirmed by the spectral analysis for the final parametric set (Ppk-neg: 40 
kPa), which revealed no broadband emissions in the frequency spectrum. Instead, the 
persistent presence of low order harmonics indicated the dominance of non-inertial 5 
cavitation throughout the entire sonication duration (figure 5(d)). On the contrary, the 
spectrogram of the first sonication parameter set (Ppk-neg: 110 kPa) produced broadband 
signatures together with higher order harmonics, thus indicating the presence of inertial 
cavitation (figure 5(b)).  
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DISCUSSION 
 
Enhancement of safe and efficient intra-cellular drug delivery 
The results presented in this paper demonstrate how the approach of incorporating 
flow in the system is desirable for successful sonoporation. The final parameters that 5 
were used (fc: 0.5 MHz, Ppk-neg: 40 kPa, PL: 50 cycles, PRF: 0.2 Hz, and Np: 500) with a 
concentration 50X the clinical dose showed a drug delivery rate of 62.6 ± 4.3% and a cell 
viability of 95 ± 4% (table 1). These parameters were deemed to produce the highest 
trans-membrane molecular delivery efficiency while avoiding cell death from within the 
limited set of parameters evaluated in our exploration protocol. Cells dislodgement from 10 
the targeted area was observed with the initial sonication parameters (fc: 0.5 MHz, Ppk-neg: 
110 kPa, PL: 100 cycles, PRF: 0.2 Hz, and Np: 50), thus it was inferred that limited low 
magnitude inertial cavitation has occurred (figure 5(b)), as shown in previous studies  
(Brayman et al., 1999). Dislodgement is not likely to occur in vivo and is an artefact of 
our in vitro system. Our results are physiologically relevant at lower pressures where cell 15 
detachment did not occur and this constitutes the majority of the parameters we explored. 
Consequently, the Ppk-neg was decreased to 40 kPa, the number of cycles was decreased 
from 100 to 50, the number of pulses was increased from 50 to 500, and the cavitation 
nuclei number was increased 50 times. The primary reason for the reduction of the 
acoustic pressure and the number of cycles was to achieve stable cavitation that is 20 
moderate and safe to the seeded cells. The rationale behind using 500 pulses was to 
increase the total number of interactions between the microbubbles undergoing the ideal 
cavitation dynamics and the cell monolayer.  Finally, the increase in the microbubble 
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concentration ensured an adequate microbubble number, uniformly distributed over the 
cell monolayer.  
The selected set of parameters led to a high delivery rate combined with high cell 
viability (figure 3(e) and table 1). Co-localization of green and red fluorescence was 
proved to be an effect of the synergistic action of the FUS and the flowing microbubbles, 5 
as indicated by the control experiments (figures 3(a)-3(c)) and the sharp boundary 
observed between the focal region and its surroundings (figures 3(d)-3(f)). By assessing 
figure 3(e), we identified three distinct types of cells, namely A, B, and C, according to 
their uptake of calcein-AM and PI. We hypothesize that PI is entering through pores 
created during or after the interaction between the microbubbles undergoing cavitation 10 
and the neighboring cell membranes. It is likely that calcein-AM has completely leaked 
out of the severely disrupted cell membrane in type B cells, thus reducing the total green 
fluorescent emission within the cytoplasm to levels below the arbitrary threshold. In type 
C cells, the limited breach of the cell membrane integrity resulted in a significant increase 
in the PI fluorescence levels when compared to type A, while a percentage of the cleaved 15 
calcein-AM molecules leaked out, yet the average green fluorescence was maintained at 
the same levels with type A ( 0.05p   ). Moderate cavitation activity (figure 5 (d)) has 
thus been shown sufficient for successful PI delivery. However, a 70% reduction was 
observed in the mean green fluorescence intensity within the sonicated region when 
compared to the non-sonicated region even in type A cells (figures 3(d), 3(f), 4(c)). A 20 
possible mechanism is that the physiology of viable cells is altered due to the external 
mechanical excitation, leading to a reduction in the emitted green fluorescence. 
Examining the origin of this reduction is part of our future work. We hypothesize that the 
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local inhomogeneity of the microbubble population characteristics, i.e. the variable 
number and size distribution, is the dominant factor contributing towards the production 
of the three distinct cell types. Other factors include the variability of the locally 
experienced ultrasound pressure, and the cycle stage of each cell which may have an 
effect on the robustness and mechanical properties of each membrane.  5 
It was also noted that time plays an important role for the PI uptake efficiency. Co-
localization of the red and green fluorescence was observed approximately 2 hours after 
sonication, indicating a time interval between mechanical agitation of the cell membrane 
and successful delivery through the membrane. The time delay is correlated with the 
relatively slow PI uptake from viable cells with a transiently permeable membrane and 10 
can be due to triggered endocytosis (Geers et al., 2011; Meijering et al., 2009), in contrast 
with dead cells with severely breached membrane that rapidly equilibrate with the 
surrounding medium’s PI concentration to give bright red fluorescence (Djuzenova et al., 
1996).  
The biological mechanism responsible for our findings is related to the cellular 15 
intake mechanism. It has been shown that membrane pore formation not only allows 
direct molecule permeation into the cytoplasm, but can also trigger transient intracellular 
defense mechanisms that can be responsible for the uptake of macromolecules (Fan et al., 
2010). Enhanced drug delivery of large molecules (>150 kDa) was previously shown to 
be a result of ultrasound-induced endocytosis (Meijering et al., 2009), which may be the 20 
cause of the delayed detection of PI fluorescence (2 hours post-sonication). PI could be 
delivered through endocytosis, but its small molecular weight (668.4 Da) may allow it to 
be transported through other routes which larger compounds cannot utilize (e.g., through 
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mechanically-induced pores)(Zhao et al. 2008). Our results were consistent with previous 
studies that verified enhanced cell membrane permeability of endothelial cells due to 
ultrasound exposure and microbubbles (van Wamel et al., 2006). Thus, we hypothesize 
that the observed trans-membrane delivery is a result of a passive transport mechanism 
coupled with non-specific membrane poration or limited physical disruption of the cell 5 
membrane due to the mechanical interaction with the oscillating microbubbles (Fan et al., 
2010; Prentice et al., 2005) which may trigger a cascade of events eventually leading to 
apoptosis (Zhong et al., 2013). 
 
Acoustic Cavitation characterization 10 
One of the goals of this study was to understand the cavitation mechanism that is 
responsible for optimum bioeffects. Inertial cavitation occurs when microbubbles respond 
to the acoustic field in a highly nonlinear manner that can be yielded with high 
temperatures and pressures (Apfel, 1997; Dalecki, 2004). This type of cavitation has been 
related to thermal mechanisms that can also result with chemical processes. Most 15 
importantly, it has been shown that cell lysis can occur from high magnitude inertial 
cavitation (Miller and Thomas 1996). Previous findings have shown how inertial 
cavitation produces violent shock waves that result in erosion of cell monolayers (Apfel 
1997; Brayman et al. 1999; Newman and Bettinger 2007). A similar effect is shown in 
the present work (figures 2(b) and 5(a)-(b)), where low magnitude inertial cavitation 20 
activity led to extensive cell detachment and cell death at the initial parametric set (fc: 0.5 
MHz, Ppk-neg: 110 kPa, PL: 100 cycles, PRF: 0.2 Hz, and Np: 50). The presence of not 
only higher order harmonics, but also broadband signal suggested that there is a mixed 
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distribution of cavitation modes (figure 5(b)). Based on this data, it is likely that 
cavitation activity spans from high magnitude non-inertial cavitation up to low magnitude 
inertial cavitation activity. Considering that the microbubble size distribution is 
polydisperse, that we are using a low center frequency of 0.5 MHz, and that our pulse 
lengths are long (greater than or equal to 50 cycles), this finding is within a reasonable 5 
range as theoretical cavitation thresholds shown previously (Apfel and Holland 1991). In 
addition, previous work with this microbubble formulation has shown that pulses emitted 
at a 0.5 MHz center frequency and in this pressure regime (Ppk-neg:147 kPa) can produce a 
mixture of high magnitude non-inertial and low magnitude inertial cavitation 
(Pouliopoulos et al. 2014), which is in agreement with the current study.   10 
In contrast, the microbubble acoustic signal analysis of the final parametric set (fc: 
0.5 MHz, Ppk-neg: 40 kPa, PL: 50 cycles, PRF: 0.2 Hz, and Np: 500) showed that stable 
cavitation was the dominant cavitation mode during the ultrasound exposure (figure 
5(d)). The low pressure and pulse length ensured safe and efficient drug delivery (figure 
3(e) and table 1), confirming previous results indicating that intact and stably oscillating 15 
microbubbles are beneficial for the sonoporation efficiency (Fan et al., 2012; van Wamel 
et al., 2006).  
The decay in the emitted energy (figures 5(a) and 5(c)) may be due to either the 
decrease of the circulating microbubble concentration or the gradual reduction of the 
microbubble sizes, originating from the natural or acoustically driven diffusion of the gas 20 
core through the lipid shell (Borden and Longo, 2002). The microbubble size distribution 
could shift towards smaller sizes, leading to a decrease of the magnitude of the radiated 
microbubble acoustic emissions (Radhakrishnan et al., 2013). Stable cavitation, i.e. 
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moderate microbubble oscillations, is crucial for the safety and efficacy of drug delivery 
via sonoporation, since the violent effects occurring within the transient cavitation regime 
such as microbubble fragmentation and jet stream formation would cause irreversible 
damage to the cell membrane and increase the cell death (figures 2(b) and 5(b)). 
 5 
Limitations of the study 
Despite the successful sonoporation effects, the major limitation of the present 
study is the variation of the mechanical effect on each individual cell, yielding three 
distinct types of cells within the focal volume (figure 3(e)). In an ideal sonoporation 
experiment, all cells would experience the same amount of mechanical agitation by the 10 
nearby oscillating microbubbles, producing only viable and sonoporated cells, i.e. type C 
cells. The effect of heterogeneous molecular uptake by sonicated cells has been described 
before (Guzmán et al., 2001a, 2001b) and constitutes a common limitation in 
sonoporation experiments. In our current studies, every effort is being made to reduce the 
variability and yield uniform sonoporation effects across the focal volume, by modifying 15 
the characteristics of the ultrasound pulse shape and sequence and standardizing the 
experimental procedure. 
In order to achieve higher trans-membrane delivery efficiency, we decided to 
increase the number of cavitation nuclei, since the previously tested concentration yielded 
a lower number of cells with evidence of trans-membrane delivery with similar 20 
sonication parameters. However the final concentration is above the recommended dose 
for imaging applications (Unger et al. 2004), and may also cause shadowing effects 
which could lead to variations of the in situ pressure experienced by the cell monolayer. 
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Therefore in our future studies the cavitation nuclei concentration will be gradually 
reduced and new pulse shapes and sequences will be designed in order to achieve the 
same bioeffect with the clinically approved concentration. One possible solution is to 
significantly increase the number of pulses emitted per unit time (i.e., increase the pulse 
repetition frequency), which would be effective due to the high microbubble 5 
replenishment rate of arterial flow. Finally, despite the improvements in the physiological 
relevance of our in vitro model, there remain several key differences with the in vivo 
conditions. Unlike the uninterrupted cell lining present in a vessel wall, here the cell 
monolayer was incomplete, subjected to flow only for 24 hours before sonication and 
kept in static conditions post-sonication. It is thus likely that the in vitro functionality and 10 
morphology of endothelial cells may not be identical to the in vivo scenario (Balcells et 
al., 2010; Rouleau et al., 2010; Sato and Ohashi, 2005). Although our flow system 
sustained a physiologically relevant flow rate, the hydrodynamic pressure was not 
controlled and this could affect the cavitation dynamics and the cell responses to 
mechanical stimuli. In terms of mechanical and acoustic properties, our flow chambers 15 
did not match the stiffness or the acoustic impedance of the vessel wall respectively. 
Moreover, the properties of blood and pure saline differ (e.g., viscosity), thus a different 
magnitude of shear stress is expected in vivo. Also, microbubble dynamics are likely to 
be affected due to the presence of other molecules (e.g., proteins) and cells (e.g., 
erythrocytes). For example, the pressure threshold for inertial cavitation is higher in 20 
blood than in water (Apfel and Holland 1991). A different acoustic response and 
reflection pattern are expected within the real vasculature. Thus, our future work involves 
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in vivo implementation of the reported pulse sequences, in order to test the safety and 
efficacy of the ultrasound-enhanced intracellular drug delivery in atherosclerotic vessels.  
Our approach to exploring the multi-dimensional ultrasonic and environmental 
parametric space was based on the accumulation of empirical evidence and adjusting the 
next series of evaluation parameters in response to this. Simultaneous modification of 5 
several parameters allowed the ability to rapidly traverse the complex and broad 
landscape of achievable microbubble dynamics. However, the limitation with this 
approach is that it does not allow us to ascertain the influence of each of these 
parameters. Modification of a single parameter at a time could help provide better insight 
into these dependencies. Regardless, we were able to achieve a bioeffect of an enhanced 10 
percentage of cells with trans-membrane delivery without exacerbating damage using our 
approach. A more comprehensive evaluation of parametric dependencies will be 
conducted in our future work. 
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CONCLUSION 
 
Our ultrasound pulse shape and sequence in the presence of specific microbubble 
and physiological parameters resulted in a intracellular drug delivery rate of 62.6 ± 4.3% 
combined with cell viability of 95% ± 4.2%, thus demonstrating the highest reported 5 
efficacy and safety during flow conditions and for endothelial cells. Cavitation analysis 
and the use of low pressures suggested that inertial cavitation was absent throughout the 
entire sonication with the selected ultrasound parameters and that stable cavitation was 
primarily responsible for the delivery. Flow and designing ultrasound parameters to 
exploit its presence was essential for producing high sonoporation efficiency without 10 
extensive cellular damage. This work lays the foundation for future work on the design 
and optimization of ultrasonic pulse shapes and sequences during flow conditions. 
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FIGURE CAPTIONS 
 
Fig. 1. Ultrasound and flow chamber experimental setup. (a) A cell flow chamber was 
connected to a closed-loop flow system composed of a peristaltic pump, tubes, and 
aspirator bottle. The bottle contained culture media, propidium iodide, and microbubbles. 5 
The cell chamber was submerged in degassed water at 37°C. A single-element focused 
ultrasound transducer with a 0.5 MHz center frequency was used for the treatment while 
a 7.5 MHz single-element passive cavitation detector was used to monitor acoustic 
cavitation activity. A PC-controlled waveform generator and a 50 dB power amplifier 
drove the 0.5 MHz FUS transducer while the captured cavitation emissions were filtered 10 
using a 1.25 MHz high-pass filter, amplified through a 28dB amplifier and then recorded 
with an oscilloscope. (b) Cell flow chamber. EA.hy926 cells were seeded in collagen 
treated flow chambers with a channel height of 400 μm with a volume of 100 μl. The 
central chamber region was sonicated (solid red circle) while other regions (dotted green 
circles) acted as non-sonicated control regions. Abbreviations: FUS: focused ultrasound; 15 
PCD: passive cavitation detector. 
 
Fig. 2. Qualitative analysis of EA.hy926 cell viability and trans-membrane delivery due 
to ultrasound exposure using our initial parameters. (a) Prior to sonication, the cells 
exhibited fluorescence (green) following administration of calcein-AM into the flow 20 
chamber. (b) Following the administration of PI (red) and microbubbles at a 1X clinical 
dose and sonication with a center frequency of 0.5 MHz, peak negative pressure of 110 
kPa, and 100-cycle pulse emitted at 0.2 Hz, 50 times, cells were observed to dislodge 
from the flow chamber. (c) By decreasing the pressure to 75 kPa and reducing the pulse 
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length to 50 cycles we avoided dislodging of cells and observed a cell that exhibited 
trans-membrane delivery (red) while maintaining cell viability (green).  
 
Fig. 3. Qualitative analysis of the EA.hy926 cell viability and trans-membrane delivery 
for the controls and our final ultrasound parameters. In all experiments, calcein-AM was 5 
first administered into the chamber followed by the flowing of culture media and PI over 
cells seeded in a flow chamber. (a) Control cells without microbubbles (–MB) and 
without sonication (–FUS). (b) Control cells without microbubbles (–MB), which were 
sonicated (+FUS) at our final parameters (fc: 0.5 MHz, Pneg: 40 kPa, PL: 50 cycles, PRF: 
0.2 Hz, Np: 500). (c) Control cells with microbubbles (+MB) at a 50X clinical dose and 10 
without sonication (–FUS). (d) - (f) Cells with microbubbles (+MB) at a 50X clinical 
dose and sonication (+FUS) (fc: 0.5 MHz, Ppk-neg: 40 kPa, PL: 50 cycles, PRF: 0.2 Hz, Np: 
500), located at the upper-left edge (d), the center of the focal region (e) and the lower-
right edge (f). Green and red cells indicate the presence of calcein-AM and PI, 
respectively. Calcein-AM represents cell viability while PI represents trans-membrane 15 
delivery.  
 
Fig. 4. Post-sonoporation fluorescence quantification for cell types A, B and C. (a) 
Examples of the different cell types within the sonicated region. (b) Lateral fluorescence 
intensity profiles across the different cell types (calcein-AM: green line, PI: red line). (c) 20 
Average fluorescence intensity measured from an ensemble of 30 randomly selected cells 
of each type. Measurements are presented as mean ± standard deviation ( 30n  ).
*: 0.001p  . 
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Fig. 5. Acoustic cavitation characterization. During sonication of microbubbles flowing 
through the cell-seeded chamber, acoustic emissions were captured using a single-
element 7.5 MHz passive cavitation detector through a (a), (b) 5 MHz or (c), (d) 1.25 
MHz high-pass filter. Sonication parameters were set to the following: (a), (b) fc: 0.5 5 
MHz, Ppk-neg: 110 kPa, PL: 100 cycles, PRF: 0.2 Hz, and Np: 50; and (c), (d) fc: 0.5 MHz, 
Ppk-neg: 40 kPa, PL: 50 cycles, PRF: 0.2 Hz, and Np: 500. (a), (c) The acoustic emissions 
energy was monitored throughout the sonication and was greater than the no microbubble 
control. Spectrograms of the microbubble acoustic emissions throughout the entire 
sonication indicate the presence of (b) harmonic and broadband emissions or (d) 10 
harmonic emissions alone.” 
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TABLE FORMATTING 
 
Table 1. Quantitative analysis of cell viability and trans-membrane delivery of the control 
and sonication experiments (Ppk-neg: 40 kPa, PL: 50 cycles, PRF: 0.2 Hz, and Np: 500, 
n=2). FUS: focused ultrasound exposure, MBs: flowing microbubbles at 50x 5 
concentration. Results are presented as mean ± standard deviation. 
Condition Cell viability (%) 
Delivery rate to 
viable cells (%) 
Flow only       99.77 ± 0.11 0 
Flow + FUS  98.50 ± 2.07 0 
Flow + MBs  98.70 ± 1.26 0 
Flow + FUS + MBs 95.00 ± 4.20 62.6 ± 4.3 
  
 
